CSIMarket
 
United guardian Inc  (UG)
Other Ticker:  
 
 
Price: $8.8742 $-0.31 -3.331%
Day's High: $9.3799 Week Perf: -2.7 %
Day's Low: $ 8.76 30 Day Perf: 5.98 %
Volume (M): 20 52 Wk High: $ 9.45
Volume (M$): $ 179 52 Wk Avg: $7.88
Open: $9.11 52 Wk Low: $5.79



 Market Capitalization (Millions $) 41
 Shares Outstanding (Millions) 5
 Employees 34
 Revenues (TTM) (Millions $) 12
 Net Income (TTM) (Millions $) 3
 Cash Flow (TTM) (Millions $) 6
 Capital Exp. (TTM) (Millions $) 0

United Guardian Inc

United-Guardian, Inc. is a Delaware corporation that, through its Guardian Laboratories Division ("Guardian"), manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, health care products, and specialty industrial products. It also conducts research and product development, primarily related to the development of new and unique cosmetic and personal care products. The Company’s research and development department also modifies, refines, and expands the uses for existing products, with the goal of further developing the market for the Companys products.

Uniteds predecessor, United International Research, Inc. ("UIR"), was founded and incorporated in New York in 1942 by Dr. Alfred R. Globus, Uniteds Chairman and Director of Research until his death on April 9, 2009. On February 10, 1982, a merger took place between UIR and Guardian Chemical Corp. ("GCC"), an affiliate of UIR, whereby GCC was merged into UIR and the name was changed to United-Guardian, Inc., a New York corporation. On September 14, 1987, United-Guardian, Inc. (New York) was merged with and into a newly-formed Delaware corporation by the same name, United-Guardian, Inc., for the purpose of changing the domicile of the Company to Delaware.

The Company manufactures and markets cosmetic ingredients, personal and health care products, medical lubricants, pharmaceuticals, and specialty industrial products. It also conducts research and development, primarily related to the development of new and unique cosmetic and personal care products. The Company focuses on the development of products that fill unmet market needs, have unique properties, and use proprietary technology that it sometimes protects with patents. Many of the Companys products are marketed through collaborative agreements with larger companies. The personal care products manufactured by the Company, including the cosmetic ingredients, are marketed to end users through the Companys worldwide network of marketing partners and distributors, and are currently used by many of the major manufacturers of cosmetic and personal care products. The Company sells product outright to its marketing partners, Ex Works (EXW) the Company’s plant in Hauppauge, New York. Those marketing partners in turn resell those products to their customers, who are typically the manufacturers and marketers of cosmetic and personal care products, and who in turn utilize the Company’s products in their finished products. The products are not sold on a consignment basis, so unless a product is determined to be defective it is not returnable except at the discretion of the Company.

The Company operates in one business segment. The Company’s products are separated into four distinct product categories: personal care products (including cosmetic ingredients), pharmaceuticals, medical products, and industrial products. Each product category is marketed differently.

The Company’s personal care products, including cosmetic ingredients, are marketed globally by six marketing partners, of which Ashland Specialty Ingredients (“ASI”), a business segment of Ashland, Inc., is the largest. The products are sold directly to those marketing partners, which in turn resell those products to its customers for use in the manufacture or compounding of the customers’ personal care and cosmetic products. The Company’s non-pharmaceutical medical products (referred to hereinafter as “medical products”) and the specialty industrial products are sold directly by the Company to the end users or to contract manufacturers utilized by the end users. The Company’s pharmaceutical products are marketed by direct advertising, mailings, and trade exhibitions, and are sold to hospitals and pharmacies primarily through full-line drug wholesalers, which purchase the Company’s products outright for resale to their customers. The Company also sells a small quantity of pharmaceutical products directly to hospitals and pharmacies. The Companys products are sold under trademarks or trade names owned by the Company, some of which are registered with the United States Patent and Trademark Office as well as comparable regulatory agencies in some foreign countries.



   Company Address: 230 Marcus Boulevard Hauppauge 11788 NY
   Company Phone Number: 273-0900   Stock Exchange / Ticker: NASDAQ UG
   


Customers Net Income fell by UG's Customers Net Profit Margin fell to

-98.76 %

0.1 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ALB   -1.97%    
CE   -2.34%    
DOW   -2.5%    
EMN   -0.38%    
HUN   -0.64%    
IFF   -2.71%    
• View Complete Report
   



Management Changes

Denise Costrini Joins United-Guardian Inc. as Marketing Director, Elevating the Company's Performance to Impressive Heights

Published Tue, May 21 2024 1:00 PM UTC



United-Guardian Inc. (NASDAQ:UG), a renowned manufacturer of cosmetic ingredients, pharmaceuticals, medical lubricants, and sexual wellness ingredients, welcomes Denise Costrini as the company's marketing director. With an extensive background spanning over 25 years in the personal care and specialty chemicals industries, Costrini brings a wealth of experience to h...

United Guardian Inc

UG Shatters Expectations with Impressive 26.636% Revenue Surge in Q1 of 2024

As a financial journalist for the CSIMarket.com, it is always fascinating to dive into the intricacies of a company's financial results and analyze what it means for their future prospects. Recently, United Guardian Inc released their first quarter 2024 financial report, and the results were a mixed bag.
While the company saw a significant surge in revenue, with a 26.636% increase from the same period last year, their profits remained stagnant at $0.00 per share. This came as a disappointment to investors, as the company had been focusing on improving sales in the most recent fiscal period. Despite the increase in revenue, United Guardian Inc was unable to translate this into profitability, leading to a net margin of 28.43%.

United Guardian Inc

United Guardian Inc Sees Modest Effort in Fourth Quarter of 2023

United Guardian Inc, a leading company in the Personal & Household Products industry, reported a weak revenue performance for the period of October to December 31, 2023. Despite this, the company managed to grow its earnings per share, with income per share increasing by 8.57% to $0.16 per share. However, the revenue dropped by -5.644% to $2.61 million, year on year.
This drop in business is in contrast to the overall trend in the industry, which experienced a revenue rise during the same period. Income per share also saw a significant growth of 14.65% from the previous quarter, increasing from $0.14 per share to $0.16 per share. On the other hand, revenue deteriorated by -14.734% from $3.06 million.

United Guardian Inc

United Guardian Inc Shines With a Marvelous 100% Income Per Share Increase in Q3 2023

United Guardian Inc, a leading company in the Personal & Household Products industry, showcased impressive growth in its financial report for the quarter ending September 30, 2023. The company experienced a remarkable increase of 100% in income per share, reaching $0.14 per share. Additionally, its revenue surged by 26.499% to reach $3.06 million.
This outstanding performance demonstrates that United Guardian Inc has outperformed its industry peers in terms of revenue growth. While the Personal & Household Products industry reported a revenue improvement of only 3.22% during the same period, United Guardian Inc achieved a substantial 26.499% growth.
Furthermore, United Guardian Inc witnessed a significant improvement in profitability, as its income per share grew by 40% from $0.10 per share in the previous year. The company also experienced a 15.365% increase in revenue, reaching $2.65 million. These figures indicate that United Guardian Inc continues to prosper despite the challenges it faces in the demanding supplier climate.

United Guardian Inc

United Guardian Inc Reports Significant EPS Decrease and Declining Financial Performance in Q2 2023

During the past 5 trading days, United Guardian Inc's stock experienced a drop of -0.51%, resulting in a year-to-date performance of -26.25%. However, despite this recent decline, the stock is still trading 8.3% above its 52-week low.
Looking at the financial performance of United Guardian Inc in the second quarter of 2023, there are some concerning indicators. The net profit per share dropped by -28.57% to $0.10 per share compared to $0.14 a year prior. Additionally, the income faded by -37.5% from $0.16 per share in the previous quarter.
The revenue of United Guardian Inc also experienced a decline, decreasing by -26.912% to $2.65 million in the second quarter of 2023 compared to $3.63 million in the same quarter a year before. However, sequentially, the revenue increased by 3.111% from $2.57 million. The net profits in the second quarter of 2023 fell by -27.19% to $0.461 million compared to break-even in the corresponding period a year earlier.
Examining the profitability margins, United Guardian Inc's operating margin mitigated to 19.55% in the second quarter of 2023, and the net margin shrank to 17.4%. These figures indicate a decrease in the company's profitability.
Due to the seasonal nature of the business, the inventories of United Guardian Inc have declined to $1.8 million from the previous quarter, although this still marks an increase relative to the same period a year ago. Moreover, the operating earnings fell by -56.82% to $0.51807 million, resulting in a decline in the operating margin to 19.55% from 33.09% in the second quarter of 2022.






 

United Guardian Inc's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
United Guardian Inc does not provide revenue guidance.

Earnings Outlook
United guardian Inc does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com